考虑使用这个工具来减少脓毒症患者抗生素相关的不良事件。

IF 1.3 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Journal of Family Practice Pub Date : 2023-01-01 DOI:10.12788/jfp.0538

Timothy Mott, Zachary Orme

引用次数: 0

摘要

预测性生物标志物降钙素原可以帮助临床决策继续抗生素治疗的患者群体。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Consider this tool to reduce antibiotic-associated adverse events in patients with sepsis.

Predictive biomarker procalcitonin can aid clinical decision-making on continued antibiotic treatment in this patient population.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Family Practice PRIMARY HEALTH CARE-MEDICINE, GENERAL & INTERNAL

CiteScore

0.50

自引率

0.00%

发文量

130

审稿时长

6-12 weeks

期刊介绍： JFP is a peer-reviewed medical journal specifically intended to meet the needs of the specialty of family medicine. JFP is delivered to more than 95,000 family physicians as well as general practitioners and osteopaths in primary care.